Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Entos Pharmaceuticals Logo
Entos Pharmaceuticals Growth Score
79
CB Rank
23779
Heat Score
68
Entos Pharmaceuticals is a clinical-stage biotech company developing genetic medicines with its Fusogenix PLV drug delivery platform.
Founded
obfuscation
PrivateGrant Edmonton, Alberta, Canada51-100 www.entospharma.com
Biotechnology
Health Care
Pharmaceutical
Overview

Entos Pharmaceuticals
Total Funding
obfuscation
Growth Score
79
Heat Score
68

Total Funding
obfuscation
Grant raised
obfuscation
Growth Score79
0 pts
in past quarter
Heat Score 68
4 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
+3 more milestones
See more interactive data and historical milestones on desktop for the best experience

About Entos Pharmaceuticals

CB Rank
23779
Entos Pharmaceuticals is a clinical-stage biotech company developing genetic medicines with its Fusogenix PLV drug delivery platform.
Founded
obfuscation
PrivateGrant Edmonton, Alberta, Canada51-100 www.entospharma.com
Biotechnology
Health Care
Pharmaceutical

Funding Rounds

Grant
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

Details

Legal Name Entos Pharmaceuticals Inc.
Operating Status Active
Company Type For Profit
Founders  Andries Zijlstra, John Lewis, Roy Duncan
About the Company
Entos develops next-generation genetic medicines using their proprietary Fusogenix proteolipid vehicle (PLV) drug delivery system. Fusogenix PLVs are formulated with FAST proteins to enable the delivery of nucleic acid into target cells through direct fusion.
Contact Email info@entospharma.com
Predictions & Insights

Growth Insight

See this Growth Insight
Entos Pharmaceuticals is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

Fusogenix PLV Platform
A drug delivery platform using FAST fusion protein technology for direct fusion delivery of genetic medicines, enabling safe, effective, and redosable nucleic acid therapies.
ENTLEP001
A gene therapy for obesity and metabolic diseases that encodes leptin hormone using the Fusogenix PLV systemic formulation to support weight loss and maintenance with once-yearly dosing.

Research & Development

Entos Pharmaceuticals is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Entos Pharmaceuticals Logo
Grant - Entos Pharmaceuticals
2
obfuscation
National Research Council of Canada Industrial Research Assistance Program, UK Research and InnovationGrant
obfuscation
Grant - Entos Pharmaceuticals Logo
Grant - Entos Pharmaceuticals
2
obfuscation
National Research Council of Canada Industrial Research Assistance Program, UK Research and InnovationGrant
obfuscation
Grant - Entos Pharmaceuticals Logo
Grant - Entos Pharmaceuticals
2
obfuscation
National Research Council of Canada Industrial Research Assistance Program, UK Research and InnovationGrant
obfuscation
Grant - Entos Pharmaceuticals Logo
Grant - Entos Pharmaceuticals
2
obfuscation
National Research Council of Canada Industrial Research Assistance Program, UK Research and InnovationGrant
obfuscation
Grant - Entos Pharmaceuticals Logo
Grant - Entos Pharmaceuticals
2
obfuscation
National Research Council of Canada Industrial Research Assistance Program, UK Research and InnovationGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Entos Pharmaceuticals Logo
Grant - Entos Pharmaceuticals
2
obfuscation
National Research Council of Canada Industrial Research Assistance Program, UK Research and InnovationGrant
obfuscation
Grant - Entos Pharmaceuticals Logo
Grant - Entos Pharmaceuticals
2
obfuscation
National Research Council of Canada Industrial Research Assistance Program, UK Research and InnovationGrant
obfuscation
Grant - Entos Pharmaceuticals Logo
Grant - Entos Pharmaceuticals
2
obfuscation
National Research Council of Canada Industrial Research Assistance Program, UK Research and InnovationGrant
obfuscation
Grant - Entos Pharmaceuticals Logo
Grant - Entos Pharmaceuticals
2
obfuscation
National Research Council of Canada Industrial Research Assistance Program, UK Research and InnovationGrant
obfuscation
Grant - Entos Pharmaceuticals Logo
Grant - Entos Pharmaceuticals
2
obfuscation
National Research Council of Canada Industrial Research Assistance Program, UK Research and InnovationGrant

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 51-100 Employee Profiles 15 Contacts 34

Employee Profiles

News

News and Press

News•Apr 21, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 20, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 20, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 6, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

828
504.38%
 in past month

IT Spend

$1.4MThis year, Entos Pharmaceuticals is projected to spend $1.4M on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Nvidia Corporation Logo
Nvidia Corporation
75
NVIDIA AI Enterprise Logo
NVIDIA AI Enterprise
73

Active Website Tech Count

2Entos Pharmaceuticals is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl and  CommonCrawl Top 5m.

Total IP

20The intellectual property of Entos Pharmaceuticals includes 12 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Entos Pharmaceuticals has registered 8 trademarks with the most popular class being 'Scientific and technological services', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Entos Pharmaceuticals's headquarters? Entos Pharmaceuticals is located in Edmonton, Alberta, Canada.Who invested in Entos Pharmaceuticals? Entos Pharmaceuticals has 4 investors including National Research Council of Canada Industrial Research Assistance Program and  UK Research and Innovation.When was the last funding round for Entos Pharmaceuticals? Entos Pharmaceuticals closed its last funding round on
obfuscation
from a Grant round.Who are Entos Pharmaceuticals's competitors? Alternatives and possible competitors to Entos Pharmaceuticals may include Sanofi, Moderna, and  Verve Therapeutics.How much funding has Entos Pharmaceuticals raised to date? Entos Pharmaceuticals has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|